At Spectra Plasmonics, we're driven by our mission to empower anyone to make better informed, human health related decisions by developing chemical sensing products that are high performing and simple to use. 

Amplifi ID™ can empower decision making and safety  for organizations involved in community drug strategy, harm reduction, overdose prevention, or drug policy.

Amplifi ID™ comes with an Integrated Drug Landscape Dashboard, enhancing your substance analysis with a suite of powerful tools.

Spectra Plasmonics was founded by a team of scientists and engineers at Queen’s University in Kingston, Ontario. The core technology in Amplifi ID was backed by years of PhD research with the aim of creating a device that enables cost-effective, high-quality chemical analysis without complex lab steps. Our founding team was passionate about healthcare solutions and saw the potential impact our technology could make towards the drug-related challenges North America was facing.

Since our founding, we have worked with dozens of people combatting North America's drug overdose crisis to help create the optimal high performing drug checking solution for the front line.